Insiders argenx SE

Equities

ARGX

NL0010832176

Biotechnology & Medical Research

Real-time Euronext Bruxelles Other stock markets 15:00:16 23/01/2026 GMT			5-day change	1st Jan Change
707.20 ^EUR	+1.17%		+2.02%	-1.28%

01-13	European Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading	MT
01-13	Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday	MT

Insiders

01-06	Argenx SE Announces CEO Changes	CI
01-06	Argenx SE Announces Management Changes	CI
01-05	Argenx SE Names Karen Massey Chief Executive	MT
01-05	Argenx SE Announces the Retirement of Peter Verhaeghe from the Board of Directors	CI
01-05	Argenx Appoints CEO to Chairman Role; COO Named Successor	MT
01-05	Karen Massey to become CEO of argenx	RE
11-06	Denali Therapeutics Inc. Announces Board and Executive Changes	CI
02/06/25	Scholar Rock Holding Corporation Announces Appointment of Rebecca Mcleod as Chief Brand Officer	CI
28/04/25	Scholar Rock Names Chairman David Hallal as CEO	MT
28/04/25	Scholar Rock Announces Executive Changes	CI
11/04/25	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday as Traders' Focus Turns to Quarterly Earnings	MT
08/07/24	Lexeo Therapeutics, Inc. Appoints Tim Van Hauwermeiren to Its Board of Directors	CI
13/06/24	Pliant Therapeutics, Inc. Appoints Steve Krognes to Its Board of Directors and Chairperson of Audit Committee	CI
08/05/24	Argenx SE Appoints Dr. Brian L. Kotzin as Non-Executive Director to the Board of Directors	CI
02/03/23	High Treasury Yields Pressure Exchange-Traded Funds, Equity Futures Premarket Thursday	MT
02/03/23	Immunology Company Argenx Appoints New COO	MT
02/03/23	Argenx Names Karen Massey as Chief Operating Officer	MT
02/03/23	Argenx Announces Planned Transition of Chief Operating Officer	CI
28/02/23	Argenx SE Appoints Steve Krognes to Board of Directors	CI
16/01/23	Argenx SE Announces Werner Lanthaler Will Resign as Non-Executive Director of Board and Chair of Audit and Compliance Committee	CI
12/12/22	Argenx SE Appoints Ana Cespedes as Non-Executive Director to Its Board of Directors	CI
27/10/22	Argenx SE Announces the Retirement of Hans De Haard as Chief Scientific Officer	CI
08/09/22	Argenx Appoints Camilla Sylvest to Board of Directors	CI
03/03/22	Argenx SE Announces Board Changes	CI
11/05/21	Argenx SE Announces Board Changes	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Insiders argenx SE

Equities

ARGX

NL0010832176

Biotechnology & Medical Research

Insiders

Filters